Collegium Pharmaceutical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US19459J1043
USD
35.44
-0.28 (-0.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
780.57
631.45
566.77
463.93
276.87
310.02
296.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
780.57
631.45
566.77
463.93
276.87
310.02
296.70
Raw Material Cost
317.31
254.10
240.60
252.34
127.99
130.18
193.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
82.31
73.97
83.34
63.21
21.01
28.88
0.91
Selling and Distribution Expenses
276.17
186.03
150.71
140.89
116.03
113.83
116.45
Other Expenses
-8.23
-7.40
-8.33
-6.19
-1.33
-1.91
0.94
Total Expenditure (Excl Depreciation)
593.48
440.14
391.31
394.53
251.73
253.78
320.45
Operating Profit (PBDIT) excl Other Income
187.10000000000002
191.29999999999998
175.5
69.4
25.099999999999998
56.2
-23.700000000000003
Other Income
11.29
13.98
15.62
1.05
0.01
0.23
1.94
Operating Profit (PBDIT)
424.45
374.45
340.33
204.84
94.09
118.07
-6.02
Interest
82.31
73.97
83.34
63.21
21.01
28.88
0.91
Exceptional Items
-23.44
-32.74
-32.00
-36.08
-7.51
0.00
0.00
Gross Profit (PBDT)
463.26
377.34
326.17
211.59
148.88
179.84
103.04
Depreciation
226.07
169.16
149.26
134.39
68.94
61.61
15.80
Profit Before Tax
92.62
98.57
75.73
-28.85
-3.37
27.58
-22.72
Tax
29.75
29.38
27.58
-3.85
-74.89
0.83
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
62.87
69.19
48.16
-25.00
71.52
26.75
-22.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
62.87
69.19
48.16
-25.00
71.52
26.75
-22.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
62.87
69.19
48.16
-25.00
71.52
26.75
-22.72
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
301.68
228.84
195.43
194.84
202.93
186.03
87.43
Earnings per share (EPS)
1.73
1.86
1.29
-0.74
1.86
0.76
-0.68
Diluted Earnings per share
1.73
1.86
1.29
-0.74
1.86
0.76
-0.68
Operating Profit Margin (Excl OI)
23.97%
30.3%
30.96%
14.96%
9.08%
18.14%
-8.0%
Gross Profit Margin
40.83%
42.4%
39.7%
22.75%
23.68%
28.77%
-2.33%
PAT Margin
8.05%
10.96%
8.5%
-5.39%
25.83%
8.63%
-7.66%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 23.63% vs 11.40% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -9.10% vs 43.57% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 14.62% vs 11.03% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 11.22% vs -11.16% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Collegium Pharmaceutical, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
780.57
425.13
355.44
83.61%
Other Operating Income
0.00
0.00
0.00
Total Operating income
780.57
425.13
355.44
83.61%
Raw Material Cost
317.31
117.61
199.70
169.80%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
82.31
16.70
65.61
392.87%
Selling and Distribution Expenses
276.17
113.17
163.00
144.03%
Other Expenses
-8.23
1.39
-9.62
-692.09%
Total Expenditure (Excl Depreciation)
593.48
261.38
332.10
127.06%
Operating Profit (PBDIT) excl Other Income
187.08
163.75
23.33
14.25%
Other Income
11.29
18.22
-6.93
-38.04%
Operating Profit (PBDIT)
424.45
222.20
202.25
91.02%
Interest
82.31
16.70
65.61
392.87%
Exceptional Items
-23.44
161.59
-185.03
-114.51%
Gross Profit (PBDT)
463.26
307.52
155.74
50.64%
Depreciation
226.07
40.23
185.84
461.94%
Profit Before Tax
92.62
326.86
-234.24
-71.66%
Tax
29.75
55.70
-25.95
-46.59%
Provisions and contingencies
0
0
0.00
Profit After Tax
62.87
271.17
-208.30
-76.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
62.87
271.17
-208.30
-76.82%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
62.87
271.17
-208.30
-76.82%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
301.68
1,172.84
-871.16
-74.28%
Earnings per share (EPS)
1.73
3.30
-1.57
-47.58%
Diluted Earnings per share
1.73
3.30
-1.57
-47.58%
Operating Profit Margin (Excl OI)
23.97%
38.52%
0.00
-14.55%
Gross Profit Margin
40.83%
86.35%
0.00
-45.52%
PAT Margin
8.05%
63.78%
0.00
-55.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 78.06 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 23.63% vs 11.40% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 6.29 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -9.10% vs 43.57% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.32 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 14.62% vs 11.03% in Dec 2024

Annual - Interest
Interest 8.23 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 11.22% vs -11.16% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.97%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024